Share this
clinical trials: the challenge of volunteer recruitment
by Neoteryx on Apr 10, 2019 8:51:00 AM
Clinical trials require recruitment, retention, and engagement. Recruitment is one of the most challenging factors, and one that must be must overcome if trial goals are to be accomplished. Poor recruitment results in trial delays, which can lead to financial losses. Recruitment of too few test subjects creates the potential for presenting biased results; more test participants are needed in order to present comprehensive and conclusive results. Here is why patient recruitment presents a challenge to the recruiters:
1. Only a small amount of budget goes into recruitment.
Recruitment of participants is as important as any other part of the clinical trial, so setting aside enough money to create awareness is needed, along with doing the best possible work within limits. This ensures the public knows of upcoming clinical trials and how to enroll.
2. Many participants are primarily interested in money.
Many people enrolling as participants in clinical trials are primarily interested in receiving money for their participation. If the money offered is not enticing enough, or if there is none, few people may be willing to participate.
Clinical trials are important in advancing healthcare and promoting the health of humans and society. People need to be aware of the impact they might make if a clinical trial presents a new medication that could change many lives. Letting people know about this could increase the number of participants, if it's done in a way that really engages people.
3. Condition-specific trials are specifically challenging.
Clinical trials that require healthy individuals are quite easy to recruit for compared to those that are condition-specific. In more specific instances, sponsors and scientists could target specific facilities that treat the condition in question and ask the health practitioners to help create awareness. In these instances, the appeal to join a trial may be early access to a medication that may provide significant health benefits compared to current treatments available.
4. Paperwork can be a deterrent.
Reams of paperwork can deter individuals from participating in clinical trials. Since the clinical trials are meant to be experimental, there’s a risk that things can go wrong. This requires a lot of paperwork that protects both parties. Simplifying the process could work in attracting interested individuals.
5. Procedural factors may be intimidating.
Individuals may fear the potential side effects, as well as the processes that take place during clinical trials. Participants may be required to frequently and consistently collect biological specimens for testing. When a trial requires blood collection through venipuncture, for example, this may deter some people from participating. Many people fear needles and blood draws. With new, minimally invasive blood collection procedures such as microsampling, it’s easier to eliminate the fear factor from clinical trials. Letting the participants know about this practically painless option for specimen collection could lead to recruiting more individuals.
Share this
- Venipuncture Alternative (106)
- Clinical Trials, Clinical Research (68)
- Mitra® Device (38)
- Research, Remote Research (32)
- Dried Blood Spot, DBS (31)
- Therapeutic Drug Monitoring, TDM (12)
- Blood Microsampling, Serology (10)
- Infectious Disease, Vaccines, COVID-19 (10)
- Decentralized Clinical Trial (DCT) (9)
- hemaPEN® Device (6)
- Pharmaceuticals, Drug Development (5)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (5)
- Antibodies, MAbs (3)
- Harpera® Tool (3)
- Omics, Multi-Omics (3)
- Skin Microsampling, Microbiopsy (3)
- Biomonitoring, Health, Wellness (2)
- March 2023 (1)
- February 2023 (2)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (6)
- October 2019 (4)
- September 2019 (5)
- August 2019 (5)
- July 2019 (4)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (6)
- January 2019 (8)
- December 2018 (3)
- November 2018 (4)
- October 2018 (7)
- September 2018 (8)
- August 2018 (6)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (5)
- February 2018 (7)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (4)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
No Comments Yet
Let us know what you think